Top of this page
Skip navigation, go straight to the content

ucb-usa.com Newsroom UCB U.S. News

Categories

  • Understanding Patients in the Workplace

    UCB_Patients at the Heart_Joy Quote_1280x960_v2
    At UCB, we approach clinical studies by engaging patients to understand what is most important to them. Our Medical Writing Specialist, Joy Avery, is able to tap into her experience as a patient herself in order to help UCB focus on what patients value. Read more from Joy about why she puts patients at the heart of everything she does.

    Read more

  • Patients Put their Trust in New Drug Discoveries

    UCB_Patients at the Heart_Miguel Quote_1280x960_v2
    At UCB, it’s about the patient and doing what the patient values, which we believe is having their best life possible. Our Senior Director, External Innovation Lead, Dr. Miguel Camargo came to UCB because he felt we were was serious about that mission and that he could make an impact through discovering medicine. Read more from Dr. Camargo about why he puts patients at the heart of everything he does.

    Read more

  • Announcing the 2019 UCB Family Epilepsy Scholarship Winners and the Addition of 6 New Scholarships

    Posted by Allyson Funk, Head of U.S. Communications and Public Affairs
    ucb_ep_scholarship_1280x960
    UCB is pleased to announce 38 recipients were awarded the 2019 UCB Family Epilepsy Scholarship. This year’s UCB Family Epilepsy Scholarship program includes six additional awards. We awarded a $10,000 Joe D’Souza Memorial Scholarship along with five additional $5,000 scholarships for 2019.

    Read more

  • A Gift that Keeps Me Running at More than 100%

    UCB_Patients at the Heart_Patty Quote_1280x960_v1
    At UCB, we go beyond just treating a person or their symptoms, it’s about seeing the person as a whole – from their emotional to physical well-being – and finding solutions that improve their care and overall quality of life. Read more from our VP of U.S. Corporate Affairs, Patty Fritz, about why she puts patients are at the heart of everything she does.

    Read more

  • Patients at the Heart

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    UCB_Patients at the Heart_blog_1280x960_v1
    We’re proud our employees are as diverse as the patients we serve – from what drives them each day to their own personal experiences that shape who they are. At UCB, we believe by encouraging our employees to channel their energy, passions, and different perspectives, we can better understand and rethink how we innovate and deliver impactful solutions patients value. Join us as we begin a 5-part series showcasing what drives UCB employees to put patients at the heart of everything they do.

    Read more

  • UCB’s strong performance enables continued investment into future growth drivers

    UCB_LOGO_1280x960
    UCB’s strong performance enables continued investment into future growth drivers

    Read more

  • UCB and DEARhealth Collaborate on New Software to Improve Patient Care

    Andrea_Epilepsy_Blog_1280x960
    UCB is collaborating with DEARhealth, Inc. to improve care delivery for people living with epilepsy. More than 1 in 26 Americans will experience epilepsy at some point in their lives, and many also suffer from stigma around their condition.

    Read more

  • Beyond What’s Required: Thoughtful Clinical Results

    DIA_for_blog
    UCB is in San Diego for DIA-Global 2019 this week. Ahead of her presentation, Liz Roberts, our Global Public Policy Lead, shares insights from the industry perspective on clinical trial disclosure and data transparency, and what UCB is doing to keep patients at the center of our work in this space. For more, see Liz speak today, June 25, 2019 at 2:00 p.m. in room 4 (session #260).

    Read more

  • UCB’s Global Clinical Development in Raleigh

    Posted by Becky Malone, Engagement and Communications
    RTP_Blog
    From discovery to development to delivery, how we do business has been transformed and redesigned around the patient’s individual experience. At UCB, patients are at the heart of everything we do, inspiring us and driving the ways in which we research, develop, and study differentiated treatments for patients. For 18 years, UCB BioSciences has been in the Research Triangle Park (RTP) in North Carolina and is an integral part of UCB’s mission to bring differentiated medicines to patients.

    Read more

  • Press Release: UCB’s Key Pipeline Molecule Bimekizumab Demonstrated Improved Outcomes for Ankylosing Spondylitis Patients

    UCB_LOGO_1280x960
    UCB’s Key Pipeline Molecule Bimekizumab Demonstrated Improved Outcomes for Ankylosing Spondylitis Patients

    Read more